NewcelX (NCEL) Assets Average (2020 - 2025)
NewcelX (NCEL) posted quarterly Assets Average of $6.0 million for Q4 2025, up 410.33% year-over-year from $1.2 million in Q4 2024, and up 772.87% quarter-over-quarter from $682000.0 in Q2 2025.
NewcelX (NCEL) Assets Average (2020 - 2025) Analysis & Trends
NewcelX (NCEL) has reported Assets Average for 6 consecutive years, with $6.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets Average rose 410.33% year-over-year to $6.0 million; the TTM figure through Dec 2025 stood at $6.0 million (up 410.33% YoY), while the FY2025 annual figure was $6.2 million, up 284.67% from the prior year.
- Assets Average grew to $6.0 million in Q4 2025 per NCEL's latest filing, from $682000.0 in the prior quarter.
- Across five years, Assets Average topped out at $7.0 million in Q4 2021 and bottomed at $682000.0 in Q2 2025.
- Historically, Assets Average has averaged $3.4 million across 5 years, with a median of $2.9 million in 2022.
- Annual changes were most pronounced in 2021 — Assets Average jumped 635.52% — and 2025, when it slumped 63.5%.
- NewcelX's Assets Average stood at $7.0 million in 2021, then slumped by 60.05% to $2.8 million in 2022, then retreated by 12.77% to $2.4 million in 2023, then tumbled by 52.3% to $1.2 million in 2024, then soared by 410.33% to $6.0 million in 2025.
- Business Quant data shows NCEL's Assets Average at $6.0 million in Q4 2025, $682000.0 in Q2 2025, and $1.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | NewcelX | 12.54 Mn | 10.34 Mn | - | 5.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.95 Mn |
| Jun 30, 2025 | 682,000.00 |
| Dec 31, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.87 Mn |
| Dec 31, 2023 | 2.45 Mn |
| Jun 30, 2023 | 3.07 Mn |
| Dec 31, 2022 | 2.80 Mn |
| Jun 30, 2022 | 3.91 Mn |
| Dec 31, 2021 | 7.02 Mn |
| Jun 30, 2021 | 4.74 Mn |
| Dec 31, 2020 | 954,003.00 |